SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-297169
Filing Date
2023-12-18
Accepted
2023-12-18 09:01:00
Documents
17
Period of Report
2023-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d584595d8k.htm   iXBRL 8-K 32718
2 EX-1.1 d584595dex11.htm EX-1.1 210866
3 EX-5.1 d584595dex51.htm EX-5.1 7491
4 EX-99.1 d584595dex991.htm EX-99.1 8851
5 EX-99.2 d584595dex992.htm EX-99.2 9057
9 GRAPHIC g584595g1214101916999.jpg GRAPHIC 2079
  Complete submission text file 0001193125-23-297169.txt   469755

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA veru-20231214.xsd EX-101.SCH 2848
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20231214_lab.xml EX-101.LAB 17995
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20231214_pre.xml EX-101.PRE 11260
11 EXTRACTED XBRL INSTANCE DOCUMENT d584595d8k_htm.xml XML 3383
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 231492375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)